Correlation Between Eton Pharmaceuticals and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Connect Biopharma Holdings, you can compare the effects of market volatilities on Eton Pharmaceuticals and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Connect Biopharma.
Diversification Opportunities for Eton Pharmaceuticals and Connect Biopharma
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eton and Connect is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Connect Biopharma go up and down completely randomly.
Pair Corralation between Eton Pharmaceuticals and Connect Biopharma
Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 0.96 times more return on investment than Connect Biopharma. However, Eton Pharmaceuticals is 1.04 times less risky than Connect Biopharma. It trades about 0.29 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about -0.17 per unit of risk. If you would invest 813.00 in Eton Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 262.00 from holding Eton Pharmaceuticals or generate 32.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eton Pharmaceuticals vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Eton Pharmaceuticals |
| Connect Biopharma |
Eton Pharmaceuticals and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eton Pharmaceuticals and Connect Biopharma
The main advantage of trading using opposite Eton Pharmaceuticals and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.| Eton Pharmaceuticals vs. Connect Biopharma Holdings | Eton Pharmaceuticals vs. Acumen Pharmaceuticals | Eton Pharmaceuticals vs. Nuvation Bio | Eton Pharmaceuticals vs. Eledon Pharmaceuticals |
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |